ED, Portfolio & Resource Analytics

Novartis; Schweiz; Hybride; CHF 157 000 - 190 000; Plein temps

Résumé du poste

Novartis AG in the US seeks an Executive Director, Portfolio & Resource Analytics to lead enterprise analytics, performance, and investment capabilities across US functions. You will drive standardization, executive reporting, and investment guidance while partnering with Finance and senior leadership.

The role manages two Director-led areas, shapes strategy, and oversees cross-functional initiatives to optimize enterprise performance and resource allocation. Hybrid出

Qualifications

• Minimum 10+ years of experience in enterprise analytics, business performance, resource allocation, strategic finance, or management consulting in pharma/healthcare.
• Proven ability to lead senior managers and build high-performing teams and establish widely adopted standards.
• Experience shaping organizational strategy and presenting a defensible point of view to senior leaders.

Responsabilités

• Lead enterprise-wide analytics and portfolio insights for US leadership.
• Oversee two Director-led capabilities: Enterprise & Functional Excellence, and Enterprise Resource Optimization.
• Set enterprise reporting standards, KPI definitions, and investment guidance.
• Interface with Finance leadership, Office of the US President, and USLT forums on performance and investments.
• Own performance vigilance processes like Monthly Business Review and Functional Business Reviews.
• Collaborate with modeling and analytics CoE to ensure integrated capabilities.

Connaissances

Enterprise analytics

Leadership

People management

Executive stakeholder engagement

Data-driven decision-making

Performance reporting

Investment/budget guidance

Formation

Bachelor's degree in Business Administration/Finance/Economics/Engineering

MBA or advanced degree preferred

Description du poste

Job Description Summary #LI-Hybrid

This position will be located at East Hanover, NJ and will not have the ability to be located remotely. This position will require 15% travel as defined by the business (domestic and/ or international).

The US Insights & Analytics (I&A) organization engineers the optimal decision environment for the US business by orchestrating, integrating, and synthesizing insights and analytics across therapeutic areas, functions, and the enterprise. Enterprise I&A drives enterprise decision environments through integrated executive analytics and portfolio insights that enable the organization to prioritize investments, track performance, and shape strategic direction.

Reporting into the VP, Head of Enterprise Insights & Analytics, the Executive Director, Portfolio & Re-source Analytics leads the enterprise-level analytics capability that answers three connected questions for US leadership: how is the business performing, where should we invest, and are our functions operating effectively. The role brings together Enterprise & Functional Excellence and Enterprise Resource Optimization under a single leader so that performance measurement and investment guidance are produced as one coherent enterprise point of view rather than as separate analytical exercises.

The Executive Director, Portfolio & Resource Analytics is a senior I&A role interfacing with Finance, the Office of the US President, and to USLT forums - accountable for the standards, methodologies, and narratives through which enterprise performance and investment decisions are framed.

Key Responsibilities:

• Enterprise and portfolio-wide scope spanning all US therapeutic areas, brands, and business functions - covering enterprise performance reporting, functional excellence, and enterprise investment and resource optimization.
• Leads two Director-led capability areas: Enterprise & Functional Excellence, and Enterprise Resource Optimization.
• Accountable for the enterprise standards that the pillar and TA teams apply, setting what "good" looks like across USLT reporting, KPI definition, and investment guidance.
• Principal I&A interface with Finance leadership, the Office of the NVS US President, and Strategy for enterprise performance and investment matters.
• Owns US enterprise/executive level Performance Vigilance processes like Monthly Business Review, Performance Pulse, Functional Business Reviews, etc
• Two-in-a-box relationship with modeling leadership in the Analytics, Capabilities & Modeling CoE, ensuring consultation and modeling operate as one capability from the stakeholder's perspective.

Essential Requirements:

• Novartis seeks a senior leader with extensive experience in the pharmaceutical or healthcare industry who has led enterprise-level analytics, performance, or investment capabilities. The successful candidate will have a proven track record of leading and developing high-performing teams including experienced managers, of establishing standards that a large organization actually adopts, and of engaging credibly with executive leadership - including holding a defensible point of view under challenge from senior finance and business stakeholders.
• Minimum 10+ years of experience in enterprise analytics, business performance, resource allocation, strategic finance, or management consulting within the pharmaceutical or healthcare industry
• Education: Bachelor's degree in Business Administration, Finance, Economics, Engineering, or a related field; an MBA or advanced degree is preferred
• Minimum 5+ years of people management experience, including leading experienced managers and building senior talent
• Demonstrated experience establishing enterprise standards, methodologies, or reporting ecosystems adopted across a large, matrixed organization
• Proven track record of enabling data-driven decision-making at executive level, including addressing complex business challenges and shaping organizational strategy
• Experience partnering directly with Finance leadership on performance, investment, budget, or headcount matters
• Working knowledge of investment optimization and marketing mix methodologies sufficient to challenge assumptions and interpret results critically
• Experience managing relationships with senior leadership and external partners, and driving complex cross-functional initiatives to completion

Desirable Requirements:

• Management consulting experience at a top-tier firm, or comparable internal strategy leadership experience; Working knowledge of the US pharmaceutical commercial model and its data and analytics ecosystem
• Experience leading multiple distinct capability areas under a single leadership remit; Experience with executive reporting to a country or regional leadership team
• Experience operating through a large-scale organizational transformation or operating model redesign; Experience building and leading capability through offshore analytics hubs
• Familiarity with GenAI and AI-enabled approaches